Neuronal antigens recognized by cerebrospinal fluid IgM in multiple sclerosis

Journal of Neuroimmunology

Volumn 247, Issue 1-2, 2012, Pages 63-69

  Beltrán, Eduardo ^a,c   Hernández, Alberto ^a   Lafuente, Eva M ^a   Coret, Francisco ^b   Simó Castelló, María ^c   Boscá, Isabel ^c   Pérez Miralles, Francisco Carlos ^c   Burgal, María ^a   Casanova, Bonaventura ^c  

^a CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Cerebral atrophy; Immunoglobulin M; Immunology; Multiple sclerosis; Neurodegeneration; Neuronal antigens

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; MEMBRANE ANTIGEN; NEURONAL ANTIGEN; OLIGOCLONAL BAND; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN ATROPHY; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEMALE; GRANULE CELL; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MALE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCREENING;

ADULT; ANTIGENS, SURFACE; CELLS, CULTURED; CEREBELLUM; ELECTROPHORESIS; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MAGNETIC RESONANCE IMAGING; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVOUS SYSTEM DISEASES; NEUROMYELITIS OPTICA; NEURONS; OLIGOCLONAL BANDS; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 84860838574     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2012.03.013     Document Type: Article

References (36)

1. Annunziata P., Pluchino S., Martino T., Guazzi G. High levels of cerebrospinal fluid IgM binding to myelin basic protein are associated with early benign course in multiple sclerosis. J. Neuroimmunol. 1997, 77:128-133.
2. Bartos A., Fialová L., Soukupová J., Kukal J., Malbohan I., Pit'ha J. Elevated intrathecal antibodies against the medium neurofilament subunit in multiple sclerosis. J. Neurol. 2007, 254(1):20-25. Jan.
3. Bell P.B., Rundquist I., Svensson I., Collins V.P. Use of cytofluorometry to evaluate binding of antibodies to the cytoskeleton of cultured cells. J. Histochem. Cytochem. 1987, 35:1381-1388.
4. Boscá I., Magraner M.J., Coret F., Alvarez-Cermeño J.C., Simó-Castelló M., Villar L.M., Casanova B. The risk of relapse after a clinically isolated syndrome is related to the pattern of oligoclonal bands. J. Neuroimmunol. 2010, 226(1-2):143-146. Sep 14.
5. Farrell M.A., Kaufmann J.C.E., Gilbert J.J., et al. Oligoclonal bands in multiple sclerosis: clinicopathologic correlation. Neurology 1985, 35:212-218.
6. Gay F.W., Drye T.J., Dick G.W., Esiri M.M. The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion. Brain 1997, 120(Pt 8):1461-1483. Aug.
7. Gorny M., Losy J., Wender M. Anti-GFAP antibodies in the cerebrospinal fluid of patients with multiple sclerosis and other neurologic diseases. Neurol. Neurochir. Pol. 1990, 24:17-22.
8. Hamilton M.A., Lehuen A., Kearney J.F. Immunofluorescence analysis of B-1 cell ontogeny in the mouse. Int. Immunol. 1994, 6:355-361.
9. Hardy R.R., Hayakawa K. CD5 B cells, a fetal B cell lineage. Adv. Immunol. 1994, 55:297-339.
10. Hasan K.M., Walimuni I.S., Abid H., Datta S., Wolinsky J.S., et al. Human brain atlas-based multimodal MRI analysis of volumetry, diffusimetry, relaxometry and lesion distribution in multiple sclerosis patients and healthy adult controls: Implications for understanding the pathogenesis of multiple sclerosis and consolidation of quantitative MRI results in MS. J. Neurol. Sci. 2012, 313(1-2):99-109. Feb 15.
11. Heymanb Regulation of antibody responses via antibodies, complement, and Fc receptors. Annu. Rev. Immunol. 2000, 18:709-737.
12. Kantor A.B., Herzenberg L.A. Origin of murine B cell lineages. Annu. Rev. Immunol. 1994, 11:501-538.
13. Langkamp M., Hörnig S.C., Hörnig J.B., Kirschner M., Pridzun L., Kornhuber M.E. Detection of myelin autoantibodies: evaluation of an assay system for diagnosis of multiple sclerosis in differentiation from other central nervous System diseases. Clin. Chem. Lab. Med. 2009, 47(11):1395-1400.
14. Magraner M.J., Bosca I., Simó-Castelló M., García-Martí G., Alberich-Bayarri A., Coret F., Alvarez-Cermeño J.C., Martí-Bonmatí L., Villar L.M., Casanova B. Brain atrophy and lesion load are related to CSF lipid-specific IgM oligoclonal bands in clinically isolated syndromes. Neuroradiology 2012, 54(1):5-12. Jan.
15. Marcaida G., Minana M.D., Burgal M., Grisolia S., Felipo V. Ammonia prevents activation of NMDA receptors by glutamate in rat cerebellar neuronal cultures. Eur. J. Neurosci. 1995, 7:2389-2396.
16. Masjuan J., Alvarez-Cermeño J.C., García-Barragán N., Díaz-Sánchez M., Espiño M., Sádaba M.C., González-Porqué P., Martínez San Millán J., Villar L.M. Clinically isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS. Neurology 2006, 66(4):576-578. Feb 28.
17. Mata S., Lolli F., Soderstrom M., Pinto F., Link H. Multiple sclerosis is associated with enhanced B cell responses to the ganglioside GD1a. Mult. Scler. 1999, 5:379-388.
18. Mongini P.K., Inman J.K., Han H., Kalled S.L., Fattah R.J., McCormick S. Innate immunity and human B cell clonal expansion: effects on the recirculating B2 subpopulation. J. Immunol. 2005, 175(9):6143-6154. Nov 1.
19. Naressi A., Couturier C., Devos J.M., Janssen M., Mangeat C., et al. Java-b ased graphical user interface for the MRUI quantitation package. MAGMA 2001, 12:141-152.
20. Obermeier B., Mentele R., Malotka J., Kellermann J., Kümpfel T., Wekerle H., Lottspeich F., Hohlfeld R., Dornmair K. Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis. Nat. Med. 2008, 14(6):688-693. Jun, Epub 2008 May 18.
21. Olsson T., Baig S., Hojeberg B., Link H. Antimyelin basic protein and antimyelin antibody-producing cells in multiple sclerosis. Ann. Neurol. 1990, 27:132-136.
22. Perini P., Ranzato F., Calabrese M., Battistin L., Gallo P. Intrathecal IgM production at clinical onset correlates with a more severe disease course in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 2006, 77:953-955.
23. Polman C.H., Reingold S.C., Edan G., Filippi M., Hartung H.P., et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann. Neurol. 2005, 58:840-846.
24. Rodriguez M., Warrington A.E., Pease L.R. Human natural autoantibodies in the treatment of neurologic disease. Neurology 2009, 72:1269-1276.
25. Rosenbluth J., Moon D. Dysmyelination induced in vitro by IgM antisulfatide and antigalactocerebroside monoclonal antibodies. J. Neurosci. Res. 2003, 71(1):104-109. Jan 1.
26. Sádaba M.C., Gonzalez-Porqué P., Masjuan J., Álvarez-Cermeño J.C., Bootello A., Villar L.M. An ultrasensitive method for the detection of oligoclonalIgG bands. J. Immunol. Methods 2004, 284:141-145.
27. Smith S.M., De Stefano N., Jenkinson M., Matthews P.M. Normalized accurate measurement of longitudinal brain change. J. Comput. Assist. Tomogr. 2001, 25:466-475.
28. Sospedra M., Martin T. Immunology of multiple sclerosis. Annu. Rev. Immunol. 2005, 23:683-747.
29. Thangarajh M., Gomez-Rial J., Hedström A.K., Hillert J., Alvarez-Cermeño J.C., Masterman T., Villar L.M. Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis. Mult. Scler. 2008, 14(9):1208-1213. Nov.
30. Villar L.M., Gonzalez-Porqué P., Masjuan J., Álvarez-Cermeño J.C., Bootello A., Keir G. A sensitiveand reproducible method for the detection of oligoclonalIgM bands. J. Immunol. Methods 2001, 258:151-155.
31. Villar L.M., Masjuan J., González-Porqué P., Plaza J., Sádaba M.C., Roldán E., Bootello A., Alvarez-Cermeño J.C. Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS. Neurology 2002, 59(4):555-559. Aug 27.
32. Villar L.M., Masjuan J., González-Porqué P., Plaza J., Sádaba M.C., Roldán E., Bootello A., Alvarez-Cermeño J.C. Intrathecal IgM synthesis is a prognostic factor in multiple sclerosis. Ann. Neurol. 2003, 53(2):222-226. Feb.
33. Villar L.M., Sádaba M.C., Roldán E., Masjuan J., González-Porqué P., Villarrubia N., Espiño M., García-Trujillo J.A., Bootello A., Alvarez-Cermeño J.C. Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS. J. Clin. Invest. 2005, 115(1):187-194. Jan.
34. Walsh M.J., Murray J.M. Dual implication of 2',3'-cyclic nucleotide 3' phosphodiesterase as major autoantigen and C3 complement-binding protein in the pathogenesis of multiple sclerosis. J. Clin. Invest. 1998, 101(9):1923-1931. May 1.
35. Walsh M.J., Tourtellotte W.W. Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA, and IgM in multiple sclerosis. J. Exp. Med. 1986, 163:41-53.
36. Wingerchuk D.W., Lennon V.A., Pittock S.J., Lucchinetti C.F., Weinshenker B.G. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006, 66:1485-1489.